56 related articles for article (PubMed ID: 21931172)
1. The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain.
Peterlongo P; Caleca L; Cattaneo E; Ravagnani F; Bianchi T; Galastri L; Bernard L; Ficarazzi F; Dall'olio V; Marme F; Langheinz A; Sohn C; Burwinkel B; Giles GG; Baglietto L; Severi G; Odefrey FA; Southey MC; Osorio A; Fernández F; Alonso MR; Benítez J; Barile M; Peissel B; Manoukian S; Radice P
J Med Genet; 2011 Oct; 48(10):703-4. PubMed ID: 21931172
[No Abstract] [Full Text] [Related]
2. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Yang R; Dick M; Marme F; Schneeweiss A; Langheinz A; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Varon R; Schott S; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Müller H; Arndt V; Brenner H; Sohn C; Burwinkel B
Breast Cancer Res Treat; 2011 Jun; 127(2):549-54. PubMed ID: 21046227
[TBL] [Abstract][Full Text] [Related]
5. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
[TBL] [Abstract][Full Text] [Related]
6. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
[TBL] [Abstract][Full Text] [Related]
7. Germline mutation of microRNA-125a is associated with breast cancer.
Li W; Duan R; Kooy F; Sherman SL; Zhou W; Jin P
J Med Genet; 2009 May; 46(5):358-60. PubMed ID: 19411564
[TBL] [Abstract][Full Text] [Related]
8. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer.
Frank B; Bermejo JL; Hemminki K; Klaes R; Bugert P; Wappenschmidt B; Schmutzler RK; Burwinkel B
J Natl Cancer Inst; 2005 Jul; 97(13):1012; author reply 1012-3. PubMed ID: 15998955
[No Abstract] [Full Text] [Related]
9. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M
Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219
[TBL] [Abstract][Full Text] [Related]
10. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.
Pastrello C; Polesel J; Della Puppa L; Viel A; Maestro R
Carcinogenesis; 2010 Dec; 31(12):2124-6. PubMed ID: 20810544
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
12. A European case-only study on familial breast cancer.
Berrino F; Pasanisi P; Berrino J; Curtosi P; Bellati C
IARC Sci Publ; 2002; 156():63-5. PubMed ID: 12484126
[No Abstract] [Full Text] [Related]
13. A BRCA1 promoter variant (rs11655505) and breast cancer risk.
Verderio P; Pizzamiglio S; Southey MC; Spurdle AB; Hopper JL; Chen X; Beesley J; ; Schmutzler RK; Engel C; Burwinkel B; Bugert P; Ficarazzi F; Manoukian S; Barile M; Wappenschmidt B; Chenevix-Trench G; Radice P; Peterlongo P
J Med Genet; 2010 Apr; 47(4):268-70. PubMed ID: 20413709
[TBL] [Abstract][Full Text] [Related]
14. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
[TBL] [Abstract][Full Text] [Related]
16. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
[TBL] [Abstract][Full Text] [Related]
17. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
18. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
19. Germ-line HER-2 variant and breast cancer risk by stage of disease.
McKean-Cowdin R; Kolonel LN; Press MF; Pike MC; Henderson BE
Cancer Res; 2001 Dec; 61(23):8393-4. PubMed ID: 11731415
[TBL] [Abstract][Full Text] [Related]
20. NBS1 variant I171V and breast cancer risk.
Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
